• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有门体静脉血管畸形的遗传性出血性毛细血管扩张症患者的轻微脑病

Minimal encephalopathy in hereditary hemorrhagic telangiectasia patients with portosystemic vascular malformations.

作者信息

Villanueva B, Cañabate A, Torres-Iglesias R, Cerdà P, Gamundí E, Ordi Q, Alba E, Sanz-Astier L A, Iriarte A, Ribas J, Castellote J, Pintó X, Riera-Mestre A

机构信息

HHT Unit. Hospital Universitari Bellvitge, C/Feixa Llarga S/N. L'Hospitalet de Llobregat, 08907, Barcelona, Spain.

Internal Medicine Department, Hospital Universitari Bellvitge, Barcelona, Spain.

出版信息

Orphanet J Rare Dis. 2024 Dec 21;19(1):484. doi: 10.1186/s13023-024-03493-3.

DOI:10.1186/s13023-024-03493-3
PMID:39709450
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11663308/
Abstract

BACKGROUND

Hereditary hemorrhagic telangiectasia (HHT) is characterized by telangiectasia and larger vascular malformations. Liver malformations are the most frequent visceral involvement including the presence of portosystemic malformations (PSM) that can cause hepatic encephalopathy. Minimal hepatic encephalopathy (mHE) is characterized by alterations of brain function in neuropsychological or neurophysiological tests and decreases quality of life. The evidence of mHE in HHT patients is scarce. The aim of this study is to assess the prevalence and health impact of mHE in patients with and without PSM.

METHODS

We performed a cross-sectional observational study in a cohort of patients from an HHT referral unit. Adult patients with definite HHT and PSM and age and sex matched HHT controls without PSM (1:1) were included. Baseline clinical, imaging and laboratory tests and different neuropsychological tests for the screening of mHE were compared between both groups.

RESULTS

Eighteen patients with PSM and 18 controls out of 430 HHT patients were included. Patients with PSM showed higher prevalence of attention disturbances (50% vs. 11.1%, p = 0.027), falls during last 12 months (22.2% vs. 5.6%, p = 0.338), sleep disorders (50% vs. 16.7%, p = 0.075) and a worst performance in s-ANT1 test (14 vs. 19.5 points score, p = 0.739) than HHT controls.

CONCLUSIONS

HHT patients with PSM showed higher attention difficulties than HHT controls, though both PSM and HHT controls showed findings of mHE. Specific neuropsychological tests for early detection of mHE should be considered in HHT patients.

摘要

背景

遗传性出血性毛细血管扩张症(HHT)的特征为毛细血管扩张和较大的血管畸形。肝脏畸形是最常见的内脏受累情况,包括存在可导致肝性脑病的门体分流畸形(PSM)。轻微肝性脑病(mHE)的特征是在神经心理学或神经生理学测试中脑功能改变,并降低生活质量。HHT患者中mHE的证据很少。本研究的目的是评估有和没有PSM的患者中mHE的患病率及其对健康的影响。

方法

我们对来自HHT转诊单位的一组患者进行了横断面观察性研究。纳入确诊为HHT且患有PSM的成年患者以及年龄和性别匹配的无PSM的HHT对照(1:1)。比较两组之间的基线临床、影像学和实验室检查以及用于筛查mHE的不同神经心理学测试。

结果

在430例HHT患者中,纳入了18例患有PSM的患者和18例对照。与HHT对照相比,患有PSM的患者出现注意力障碍的患病率更高(50%对11.1%,p = 0.027)、过去12个月内跌倒的发生率更高(22.2%对5.6%,p = 0.338)、睡眠障碍的发生率更高(50%对16.7%,p = 0.075),并且在s-ANT1测试中的表现更差(得分分别为14分和19.5分,p = 0.739)。

结论

患有PSM的HHT患者比HHT对照表现出更高的注意力困难,尽管PSM患者和HHT对照均显示出mHE的表现。对于HHT患者,应考虑采用特定的神经心理学测试来早期检测mHE。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cbb/11663308/2393077fa5e1/13023_2024_3493_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cbb/11663308/869c67cf37ec/13023_2024_3493_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cbb/11663308/6a85ff242311/13023_2024_3493_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cbb/11663308/2393077fa5e1/13023_2024_3493_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cbb/11663308/869c67cf37ec/13023_2024_3493_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cbb/11663308/6a85ff242311/13023_2024_3493_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1cbb/11663308/2393077fa5e1/13023_2024_3493_Fig3_HTML.jpg

相似文献

1
Minimal encephalopathy in hereditary hemorrhagic telangiectasia patients with portosystemic vascular malformations.患有门体静脉血管畸形的遗传性出血性毛细血管扩张症患者的轻微脑病
Orphanet J Rare Dis. 2024 Dec 21;19(1):484. doi: 10.1186/s13023-024-03493-3.
2
Hereditary Hemorrhagic Telangiectasia Induced Portosystemic Encephalopathy: A Case Report and Literature Review.遗传性出血性毛细血管扩张症相关门脉系统脑病:病例报告及文献复习。
Intern Med. 2021 May 15;60(10):1541-1545. doi: 10.2169/internalmedicine.5670-20. Epub 2020 Dec 22.
3
Minimal portosystemic encephalopathy: A new nosological entity in patients with hereditary haemorrhagic telangiectasia.微小型门体系统脑病:遗传性出血性毛细血管扩张症患者的一种新的分类实体。
Eur J Intern Med. 2021 Aug;90:43-48. doi: 10.1016/j.ejim.2021.04.026. Epub 2021 May 18.
4
Liver involvement in hereditary hemorrhagic telangiectasia (HHT).遗传性出血性毛细血管扩张症(HHT)中的肝脏受累情况。
J Hepatol. 2007 Mar;46(3):499-507. doi: 10.1016/j.jhep.2006.12.008. Epub 2007 Jan 2.
5
Ammonia Predicts Hepatic Involvement and Pulmonary Hypertension in Patients With Hereditary Hemorrhagic Telangiectasia.氨预测遗传性出血性毛细血管扩张症患者的肝脏受累和肺动脉高压。
Clin Transl Gastroenterol. 2020 Jan;11(1):e00118. doi: 10.14309/ctg.0000000000000118.
6
Pulmonary gas exchange in hereditary hemorrhagic telangiectasia patients with liver arteriovenous malformations.遗传性出血性毛细血管扩张症伴肝动静脉畸形患者的肺气体交换。
Respir Res. 2019 Jul 4;20(1):137. doi: 10.1186/s12931-019-1106-y.
7
Molecular mechanisms and clinical manifestations of hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的分子机制和临床表现。
Thromb Res. 2024 Sep;241:109117. doi: 10.1016/j.thromres.2024.109117. Epub 2024 Aug 12.
8
Abdominal manifestations of hereditary hemorrhagic telangiectasia: a series of 333 patients over 15 years.遗传性出血性毛细血管扩张症的腹部表现:15 年以上 333 例患者系列。
Abdom Radiol (NY). 2019 Jul;44(7):2384-2391. doi: 10.1007/s00261-019-01976-7.
9
Central nervous system manganese induced lesions and clinical consequences in patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者中枢神经系统锰诱导的病变及临床后果
Orphanet J Rare Dis. 2017 May 18;12(1):92. doi: 10.1186/s13023-017-0632-2.
10
Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.常见候选变异与遗传性出血性毛细血管扩张症中血管畸形和颅内出血的关联
Mol Genet Genomic Med. 2018 May;6(3):350-356. doi: 10.1002/mgg3.377. Epub 2018 Mar 6.

本文引用的文献

1
Comparison of 6 tests for diagnosing minimal hepatic encephalopathy and predicting clinical outcome: A prospective, observational study.比较 6 种用于诊断轻微型肝性脑病和预测临床结局的检测方法:一项前瞻性、观察性研究。
Hepatology. 2024 Aug 1;80(2):389-402. doi: 10.1097/HEP.0000000000000770. Epub 2024 Feb 13.
2
Risk factors and clinical features associated with basal ganglia manganese deposition in patients with hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症患者基底节区锰沉积的相关危险因素和临床特征。
Clin Imaging. 2023 Sep;101:183-189. doi: 10.1016/j.clinimag.2023.06.012. Epub 2023 Jun 24.
3
Comparison of the effects of probiotics, rifaximin, and lactulose in the treatment of minimal hepatic encephalopathy and gut microbiota.
益生菌、利福昔明和乳果糖治疗轻微肝性脑病及肠道微生物群的效果比较
Front Microbiol. 2023 Mar 24;14:1091167. doi: 10.3389/fmicb.2023.1091167. eCollection 2023.
4
Minimal Hepatic Encephalopathy Affects Daily Life of Cirrhotic Patients: A Viewpoint on Clinical Consequences and Therapeutic Opportunities.轻微肝性脑病影响肝硬化患者的日常生活:关于临床后果及治疗机遇的观点
J Clin Med. 2022 Dec 6;11(23):7246. doi: 10.3390/jcm11237246.
5
Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review.出血性遗传性毛细血管扩张症患者肝移植的围手术期并发症及长期随访:三例报告及系统评价
J Clin Med. 2022 Sep 24;11(19):5624. doi: 10.3390/jcm11195624.
6
[A case of hepatic encephalopathy induced by hereditary hemorrhagic telangiectasia].[一例由遗传性出血性毛细血管扩张症诱发的肝性脑病]
Zhonghua Gan Zang Bing Za Zhi. 2022 Mar 20;30(3):323-325. doi: 10.3760/cma.j.cn501113-20210128-00047.
7
Diffuse Cerebral Edema and Impending Herniation Complicating Hepatic Encephalopathy in Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症合并肝性脑病时的弥漫性脑水肿及即将发生的脑疝
Case Rep Med. 2022 Feb 18;2022:2612544. doi: 10.1155/2022/2612544. eCollection 2022.
8
Minimal portosystemic encephalopathy: A new nosological entity in patients with hereditary haemorrhagic telangiectasia.微小型门体系统脑病:遗传性出血性毛细血管扩张症患者的一种新的分类实体。
Eur J Intern Med. 2021 Aug;90:43-48. doi: 10.1016/j.ejim.2021.04.026. Epub 2021 May 18.
9
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症诊断与管理的第二版国际指南。
Ann Intern Med. 2020 Dec 15;173(12):989-1001. doi: 10.7326/M20-1443. Epub 2020 Sep 8.
10
Current HHT genetic overview in Spain and its phenotypic correlation: data from RiHHTa registry.西班牙目前的 HHT 遗传概述及其表型相关性:RiHHTa 注册中心的数据。
Orphanet J Rare Dis. 2020 Jun 5;15(1):138. doi: 10.1186/s13023-020-01422-8.